Shigella

9,334views

Shigella

GI System

GI System

Escherichia coli
Salmonella (non-typhoidal)
Yersinia enterocolitica
Clostridium difficile (Pseudomembranous colitis)
Enterobacter
Salmonella typhi (typhoid fever)
Clostridium perfringens
Vibrio cholerae (Cholera)
Shigella
Norovirus
Bacillus cereus (Food poisoning)
Campylobacter jejuni
Bacteroides fragilis
Rotavirus
Gastrointestinal hormones
Vitamins and minerals
Intestinal fluid balance
Prebiotics and probiotics
Sialadenitis
Parotitis
Oral candidiasis
Aphthous ulcers
Ludwig angina
Warthin tumor
Oral cancer
Dental caries disease
Dental abscess
Gingivitis and periodontitis
Temporomandibular joint dysfunction
Nasal, oral and pharyngeal diseases: Pathology review
Esophageal disorders: Pathology review
Esophageal web
Esophagitis: Clinical
Barrett esophagus
Achalasia
Zenker diverticulum
Diffuse esophageal spasm
Esophageal cancer
Esophageal disorders: Clinical
Boerhaave syndrome
Plummer-Vinson syndrome
Tracheoesophageal fistula
Mallory-Weiss syndrome
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastroesophageal reflux disease (GERD)
Peptic ulcer
Helicobacter pylori
Gastritis
Peptic ulcers and stomach cancer: Clinical
Pyloric stenosis
Zollinger-Ellison syndrome
Gastric dumping syndrome
Gastroparesis
Gastric cancer
Gastroenteritis
Small bowel bacterial overgrowth syndrome
Irritable bowel syndrome
Celiac disease
Small bowel ischemia and infarction
Tropical sprue
Short bowel syndrome (NORD)
Malabsorption syndromes: Pathology review
Malabsorption: Clinical
Zinc deficiency and protein-energy malnutrition: Pathology review
Whipple's disease
Appendicitis: Pathology review
Appendicitis
Appendicitis: Clinical
Lactose intolerance
Protein losing enteropathy
Microscopic colitis
Inflammatory bowel disease: Pathology review
Crohn disease
Ulcerative colitis
Inflammatory bowel disease: Clinical
Bowel obstruction
Bowel obstruction: Clinical
Volvulus
Familial adenomatous polyposis
Juvenile polyposis syndrome
Gardner syndrome
Colorectal polyps and cancer: Pathology review
Colorectal polyps
Colorectal cancer
Colorectal cancer: Clinical
Peutz-Jeghers syndrome
Diverticulosis and diverticulitis
Diverticular disease: Pathology review
Diverticular disease: Clinical
Intestinal adhesions
Ischemic colitis
Peritonitis
Pneumoperitoneum
Cyclic vomiting syndrome
Abdominal hernias
Femoral hernia
Inguinal hernia
Hernias: Clinical
Congenital gastrointestinal disorders: Pathology review
Congenital diaphragmatic hernia
Imperforate anus
Gastroschisis
Omphalocele
Meckel diverticulum
Intestinal atresia
Hirschsprung disease
Intestinal malrotation
Necrotizing enterocolitis
Intussusception
Anal conditions: Clinical
Anal fissure
Anal fistula
Hemorrhoid
Rectal prolapse
Carcinoid syndrome
Crigler-Najjar syndrome
Biliary atresia
Gilbert's syndrome
Dubin-Johnson syndrome
Rotor syndrome
Jaundice: Pathology review
Jaundice
Cirrhosis
Cirrhosis: Pathology review
Cirrhosis: Clinical
Portal hypertension
Hepatic encephalopathy
Hemochromatosis
Wilson disease
Budd-Chiari syndrome
Non-alcoholic fatty liver disease
Cholestatic liver disease
Hepatocellular adenoma
Alcohol-associated liver disease
Alpha 1-antitrypsin deficiency
Primary biliary cholangitis
Viral hepatitis
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis: Pathology review
Viral hepatitis: Clinical
Autoimmune hepatitis
Primary sclerosing cholangitis
Neonatal hepatitis
Reye syndrome
Benign liver tumors
Hepatocellular carcinoma
Gallbladder disorders: Pathology review
Gallstones
Gallstone ileus
Biliary colic
Acute cholecystitis
Ascending cholangitis
Chronic cholecystitis
Gallbladder carcinoma
Gallbladder disorders: Clinical
Cholangiocarcinoma
Pancreatic pseudocyst
Acute pancreatitis
Chronic pancreatitis
Pancreatitis: Clinical
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Pancreatitis: Pathology review
Abdominal trauma: Clinical
Gastrointestinal bleeding: Pathology review
Gastrointestinal bleeding: Clinical
Pediatric gastrointestinal bleeding: Clinical
Abdominal pain: Clinical
Disorders of carbohydrate metabolism: Pathology review
Glycogen storage disorders: Pathology review
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Environmental and chemical toxicities: Pathology review
Medication overdoses and toxicities: Pathology review
Laxatives and cathartics
Antidiarrheals
Acid reducing medications

Transcript

Watch video only

Shigella is a Gram-negative bacterium that belongs to the Enterobacteriaceae family.

There are 4 species of Shigella:

S. dysenteriae, S. flexneri; S. boydii; and S. sonnei, and each has its own serotypes.

In humans these species can all cause Shigellosis, which is a contagious infection of the intestines, particularly the colon.

And shigellosis can progress to dysentery, which is when the infection causes inflammation of the colon, resulting in severe abdominal pain and diarrhea.

Now, Shigella is a gram-negative, rod shaped bacterium, meaning it looks like a little red or pink stick on a gram stain.

And it’s a facultative anaerobe, so it can survive with or without oxygen in the environment.

It has no flagellum, making it nonmotile; and it doesn’t form spores.

It’s also a non-lactose fermenter, so it doesn’t ferment lactose; and it’s urease and oxidase-negative, meaning it doesn’t produce these enzymes.

Finally, it doesn’t produce hydrogen sulfide gas either, and this can be used to selectively identify Shigella on special culture mediums like MacConkey agar.

On this medium, Shigella mostly forms white, non-lactose fermenting, non-hydrogen sulfide-producing colonies

Now, once Shigella is ingested, it multiplies in the small intestine, and then passes into the colon.

There, it targets the epithelial layer of the mucosal lining where it infects colonic enterocytes and microfold cells, or M-cells.

And these M-cells phagocytose, which means they eat the bacteria from the intestinal lumen, and then spit it out into the underlying mucosa-associated lymphoid tissues, or MALTs.

MALTs are a type of mucosal immune tissue that extends into the submucosa, and contains plenty of immune cells like macrophages.

The macrophages gobble up Shigella to neutralize the pathogen, but the bacterium induces apoptosis, or programmed cell death, in the macrophage.

Now, when a macrophage dies, it releases a variety of cytokines, including IL-1β, which activates an intense inflammatory process that recruits additional immune cells to wage war at the site of infection.

And this results in the death of epithelial cells, which damages the colonic mucosa, resulting in ulcerations and abscesses.

All the damage and migration of immune cells, particularly polymorphonuclear leukocytes, through the epithelium disrupts the cellular junctions between neighboring epithelial cells, allowing Shigella from the intestinal lumen to enter enterocytes through the lateral sides of the cell.

And actually, that’s not the only way Shigella can infect enterocytes after the initial infection:

After Shigella kills the macrophage and is released into the immune tissue under the epithelium, it can access and infect colonic enterocytes from their basal side.

Shigella uses its type III secretory system, which acts almost like a syringe, to puncture and inject proteins into enterocytes that makes the enterocytes phagocytose Shigella.

So that means Shigella is slowly engulfed by the cell membrane, forming a membrane bound compartment that eventually pinches off from the cell membrane and ends up inside the cell, where it’s called a phagosome.

Then, Shigella can use a number of effector proteins, which lyse the phagosome and release Shigella into the cytoplasm.

In the cytoplasm, effector proteins also induce Shigella’s actin-based motility.

This starts by recruiting the host cell’s small actin filaments to one end of the bacteria.

And as more and more actin filaments get recruited and polymerize behind the bacteria’s end pole, that propels the bacteria forward, like a rocket.

That helps Shigella “blast” through the lateral sides of both the host enterocyte and, after, the neighboring enterocyte, further spreading the infection.

Finally, one particular species of Shigella, S. dysenteriae serotype 1, also produces Shiga toxin.

Shiga toxin, similar to the shiga-like toxin producing pathotype of E. coli, is an AB toxin, so it has two main subunits, A and B, that are joined by a disulfide bond.

Each subunit plays a specific role in the invasion and destruction of a host cell.

The B subunit helps bind the toxin to the host’s cell membrane, where the toxin is ultimately engulfed into a phagosome.

Within the host’s cell cytoplasm, the inside of the phagosome becomes more acidic, and as a consequence, the disulfide bond holding the two subunits together becomes weak and eventually break, separating the subunits.

At this point, the A subunit can then diffuses through the phagosome membrane into the cytoplasm, where it targets the ribosomes.

In eukaryotic cells, ribosomes are made of two main subunits; the larger of the two is the 60S subunit, and it contains a 28S rRNA protein that’s important for the initiation of polypeptide synthesis.

Key Takeaways

Shigella is a genus of bacteria known to cause a contagious form of gastroenteritis known as shigellosis. Shigellosis is characterized by an inflammation of the gastrointestinal tract, which causes destruction and inflammation of the epithelium, leading to dysentery with symptoms like severe abdominal and rectal cramping and pain, a fever, and watery diarrhea with mucous with or without blood or pus. Shigella is transmitted through the fecal-to-oral route, mainly through fingers, food, and flies. It's diagnosed with a fecal sample and treatment centers around fluid and electrolyte replenishment and antibiotics.